SOURCE: Cerora, Inc.

Cerora, Inc.

January 14, 2014 15:11 ET

Cerora CEO Presents Proprietary "Near the Field" Concussion Assessment Technologies at OneMedForum Investor Conference

Use of Multiple Biosensors Enables Objective Measures Outside the Hospital

SAN FRANCISCO, CA--(Marketwired - Jan 14, 2014) - Cerora, Inc., a StartUp Health Academy GE Entrepreneurship program company, presented their portable, objective "near the field" technology yesterday during the OneMedForum Early Stage Investor conference at San Francisco's Westin Market Street hotel during the JP Morgan Healthcare activities. Speaking to a full roomful of healthcare investors, CEO Adam Simon outlined Cerora's strategy for developing and commercializing multiple-biosensor technologies which are able to make objective measurements of brain health possible outside of the clinic or hospital. As part of the presentation, Simon conducted a live demonstration of Cerora's proprietary MindReader™ technology by remotely examining the brainwaves of colleagues in attendance and showing the results to the audience on-screen in real time. An additional interview was conducted and should be available shortly.

Cerora is actively engaging with investors to fund the company's development plans for the future.

More About Cerora, Inc.
Cerora, Inc. is leading the way in the development and testing of software and hardware technologies required to provide critically important objective, portable biomarker-based brain-function diagnostic information. Located in the high-tech nexus at Ben Franklin Technology Partners of Northeastern Pennsylvania on Lehigh University's Mountaintop Campus in Bethlehem, Pennsylvania, the Company has assembled a team of experienced medical scientists and management professionals under the leadership of CEO Adam J. Simon, PhD, a noted physicist and globally-recognized brain biomarker expert.

For additional information please visit www.cerora.com.

Contact Information